Table S6 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer
<p>Suppl. Table S6, Copy number from whole exome sequencing</p>
Bewaard in:
| Hoofdauteur: | Nina Müller (16721126) (author) |
|---|---|
| Andere auteurs: | Carina Lorenz (16721129) (author), Jenny Ostendorp (16721132) (author), Felix S. Heisel (16721135) (author), Ulrich P. Friese (16721138) (author), Maria Cartolano (16721141) (author), Dennis Plenker (14956116) (author), Hannah Tumbrink (16721144) (author), Alena Heimsoeth (16721147) (author), Philipp Baedeker (16721150) (author), Jonathan Weiss (16721153) (author), Sandra Ortiz-Cuaran (15439111) (author), Reinhard Büttner (15135528) (author), Martin Peifer (15135504) (author), Roman K. Thomas (15135513) (author), Martin L. Sos (15090597) (author), Johannes Berg (16721156) (author), Johannes Brägelmann (15030440) (author) |
| Gepubliceerd in: |
2025
|
| Onderwerpen: | |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Gelijkaardige items
-
Table S5 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer
door: Nina Müller (16721126)
Gepubliceerd in: (2025) -
Table S7 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer
door: Nina Müller (16721126)
Gepubliceerd in: (2025) -
Table S8 from Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer
door: Nina Müller (16721126)
Gepubliceerd in: (2025) -
Supplementary Tables from <i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
door: Elisa ten Hacken (15136187)
Gepubliceerd in: (2025) -
TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
door: Lavanya Sivapalan (15314248)
Gepubliceerd in: (2025)